^
    dMMR/MSI-H + TMB-L
    Pancreatic Cancer
    PD1 inhibitor
    Resistant
    :
    C3
    Clin Cancer Res - 1wk
    PTEN mutation + MSI-H/dMMR
    Pancreatic Cancer
    PD1 inhibitor
    Resistant
    :
    C3
    Clin Cancer Res - 1wk
    BRCA2 mutation
    Pancreatic Cancer
    olaparib
    Sensitive
    :
    A1
    BRCA1 mutation
    Pancreatic Cancer
    olaparib
    Sensitive
    :
    A1
    No biomarker
    Pancreatic Adenocarcinoma
    gemcitabine + albumin-bound paclitaxel
    Sensitive
    :
    A1
    No biomarker
    Pancreatic Adenocarcinoma
    5-fluorouracil + leucovorin calcium + nanoliposomal irinotecan
    Sensitive
    :
    A1
    No biomarker
    Pancreatic Cancer
    erlotinib
    Sensitive
    :
    A1
    No biomarker
    Pancreatic Cancer
    GEM-CAP
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    LV5FU2
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    CAPOX
    Sensitive
    :
    A2
    NTRK3 fusion
    Pancreatic Adenocarcinoma
    larotrectinib
    Sensitive
    :
    A2
    NTRK2 fusion
    Pancreatic Adenocarcinoma
    larotrectinib
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Cancer
    5-fluorouracil + nanoliposomal irinotecan
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Cancer
    5-fluorouracil + oxaliplatin
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Cancer
    5-fluorouracil
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Cancer
    5-fluorouracil + irinotecan
    Sensitive
    :
    A2
    NTRK3 fusion
    Pancreatic Adenocarcinoma
    entrectinib
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Cancer
    gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    erlotinib
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    capecitabine
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    5-fluorouracil + capecitabine
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    5-fluorouracil
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Pancreatic Adenocarcinoma
    gemcitabine + capecitabine
    Sensitive
    :
    A2
    BRCA1 mutation
    Pancreatic Adenocarcinoma
    cisplatin + gemcitabine
    Sensitive
    :
    A2
    BRCA2 mutation
    Pancreatic Adenocarcinoma
    cisplatin + gemcitabine
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES